Multiple myeloma: significance of plasmablastic subtype in morphological classification

Area of Science:

• Hematology
• Oncology
• Pathology

Background:

• Myeloma classification is crucial for prognosis.
• Pre-chemotherapy morphological classification can inform treatment strategies.

Purpose of the Study:

• To classify 100 myeloma cases before chemotherapy.
• To evaluate the prognostic significance of different myeloma subtypes, particularly plasmablastic myeloma.

Main Methods:

• Morphological classification of 100 myeloma cases into mature, intermediate, immature, and plasmablastic subtypes.
• Kaplan-Meier survival analysis to compare median survival between subtypes.

Main Results:

• Plasmablastic myeloma (15 cases) showed a median survival of 10 months, significantly shorter than other subtypes (35 months).
• Increased early mortality was observed in the plasmablastic group.
• Plasmablastic myeloma was linked to higher rates of renal insufficiency and plasma cell labeling indices.

Conclusions:

• Plasmablastic myeloma is an aggressive subtype with poor prognosis.
• Early identification of plasmablastic myeloma may guide intensified treatment approaches.
• Further research into the mechanisms driving poor survival in plasmablastic myeloma is warranted.